Cargando…
A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study)
Autores principales: | Wang-Gillam, Andrea, Picozzi, Vincent, Crocenzi, Todd, Morse, Michael, Zeh, Herbert, Fine, Robert, Murphy, Aimee, Skoble, Justin, Lemmens, Edward, Ferber, Sandy, Rosen, Allan, Grous, John, Dubensky, Thomas W, Brockstedt, Dirk, Jaffee, Elizabeth, Le, Dung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288721/ http://dx.doi.org/10.1186/2051-1426-2-S3-P68 |
Ejemplares similares
-
Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)
por: Le, Dung T, et al.
Publicado: (2015) -
Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
por: Nair, Nitya, et al.
Publicado: (2015) -
Anti-mesothelin vaccine CRS-207 with or without low-dose cyclophosphamide plus chemotherapy as front-line treatment for malignant pleural mesothelioma (MPM)
por: Hassan, Raffit, et al.
Publicado: (2015) -
Levels in $^{207}$Po populated in the decay of $^{207}$At
por: Jonson, B, et al.
Publicado: (1970) -
Levels in $^{207}Po$ populated in the decay of $^{207}At$
por: Jonson, B, et al.
Publicado: (1971)